IAPP/amylin gene transcriptional control region: evidence for negative regulation
- 1 October 1990
- journal article
- Published by Wiley in FEBS Letters
- Vol. 271 (1-2) , 33-36
- https://doi.org/10.1016/0014-5793(90)80365-p
Abstract
Aberrant expression of the islet amyloid polypeptide (IAPP) gene might be involved in the pathogenesis of nun‐insulin‐dependent diabetes mellitus (NIDDM). Here, we report that IAPP promoter‐luciferase constructs revealed tissue‐specific activity. This activity was not mediated by cAMP. Sequential 5' deletions of the IAPP promoter caused a progressive derepression of the IAPP gene promoter in IAPP‐producing cells. Comparison of the nucleotide sequence of the IAPP promoter with that of the insulin promoter (both active in pancreatic β‐cells) reveals two sequence elements of putative importance: an insulin enhancer‐like sequence and an element which corresponds to a protected domain in rat insulin I gene promoter footprint experiments.Keywords
This publication has 30 references indexed in Scilit:
- Reduced islet-amyloid polypeptide in insulin-dependent diabetes mellitusThe Lancet, 1990
- Cosecretion of amylin and insulin from isolated rat pancreasFEBS Letters, 1990
- Islet-amyloid polypeptide in human plasmaThe Lancet, 1990
- Secretion of islet amyloid polypeptide in response to glucoseFEBS Letters, 1989
- EXPRESSION OF THE RAT AMYLIN (IAPP / DAP) GENE.Journal of Molecular Endocrinology, 1989
- The complete islet amyloid polypeptide precursor is encoded by two exonsFEBS Letters, 1989
- Islet amyloid polypeptide: Identification and chromosomal localization of the human geneFEBS Letters, 1988
- Pancreatic amylin and calcitonin gene-related peptide cause resistance to insulin in skeletal muscle in vitroNature, 1988
- ISLET AMYLOID FORMED FROM DIABETES-ASSOCIATED PEPTIDE MAY BE PATHOGENIC IN TYPE-2 DIABETESThe Lancet, 1987
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976